HCID 59150509, Verbindung → 10-methyl-7-(4-{[4-methyl-5-(2-methyl-5-quinolinyl)-4H-1,2,4-triazol-3-yl]thio}butyl)-2-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,3]oxazolo[4,5-h][3]benzazepine hydrochloride
Reaktionsgleichung
[CH3:1][C:2]1[C:12]2[CH2:11][CH2:10][NH:9][CH2:8][CH2:7][C:6]=2[CH:5]=[C:4]2[N:13]=[C:14]([C:16]([F:19])([F:18])[F:17])[O:15][C:3]=12.[Cl:20][CH2:21][CH2:22][CH2:23][CH2:24][S:25][C:26]1[N:27]([CH3:42])[C:28]([C:31]2[CH:40]=[CH:39][CH:38]=[C:37]3[C:32]=2[CH:33]=[CH:34][C:35]([CH3:41])=[N:36]3)=[N:29][N:30]=1>>[ClH:20].[CH3:1][C:2]1[C:12]2[CH2:11][CH2:10][N:9]([CH2:21][CH2:22][CH2:23][CH2:24][S:25][C:26]3[N:27]([CH3:42])[C:28]([C:31]4[CH:40]=[CH:39][CH:38]=[C:37]5[C:32]=4[CH:33]=[CH:34][C:35]([CH3:41])=[N:36]5)=[N:29][N:30]=3)[CH2:8][CH2:7][C:6]=2[CH:5]=[C:4]2[N:13]=[C:14]([C:16]([F:19])([F:17])[F:18])[O:15][C:3]=12Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
The title compound was prepared in analogy to General Procedure 1 from 10-methyl-2-(trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,3]oxazolo[4,5-h][3]benzazepine (120 mg) and 5-{5-[(4-chlorobutyl)thio]-4-methyl-4H-1,2,4-triazol-3-yl}-2-methylquinoline (224 mg) and was obtained according as a colourless slightly hygroscopic solid (163 mg).